The activity against lymphocytic leukemia P 388 has been evaluated for thirteen compounds bearing a quinolizidine moiety bound respectively to a phenothiazine nucleus or other isosteric tricyclic systems (12-17), as well to a quinoxalinone (18-20) or an indole (21-24) nucleus. All tested compounds resulted inactive.
Quinolizidine derivatives as potential antitumoral agents / A. Sparatore, C. Boido Canu, V. Boido, F. Sparatore. - In: IL FARMACO. - ISSN 0014-827X. - 44:10(1989 Oct), pp. 945-950.
Quinolizidine derivatives as potential antitumoral agents
A. SparatorePrimo
;
1989
Abstract
The activity against lymphocytic leukemia P 388 has been evaluated for thirteen compounds bearing a quinolizidine moiety bound respectively to a phenothiazine nucleus or other isosteric tricyclic systems (12-17), as well to a quinoxalinone (18-20) or an indole (21-24) nucleus. All tested compounds resulted inactive.File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.